Human Embryonic Stem Cells Market to Benefit from Expanding Stem Cell Banking Services

A new market research study by Transparency Market Research offers a comprehensive analysis of the human embryonic stem cells market across the globe. The research report, titled “Human Embryonic Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” further presents the forecast statistics of the overall market with the help of tables, charts, and infographics.

Donwload Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1593

Human embryonic stem cells have the capability of differentiating into a number of cell types that make up the human body. Stem cells are derived from blastocysts and can replicate indefinitely and can also produce non-regenerative tissues, including myocardial and neural cells. As a result, human embryonic stem cells are increasingly being used for treating several genetic and blood disorders such as cancer and various disorders related to the immune system.

The growing research and development activities in the human embryonic stem cells market are one of the major factors fuelling the growth of the market. In addition, developing stem cell banking services and growing medical tourism are further augmenting the growth of the global market for human embryonic stem cells throughout the forecast period. Moreover, the growing incidence of neurological and cardiac disorders worldwide, due to the hectic lifestyle of the global population, and increasing availability of funds from several organizations are also estimated to fuel the growth of the market.

The global market for human embryonic stem cells has been segmented on the basis of application into regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing. The technological advancement in this field is estimated to increase its application in diverse sectors, resulting in rapid growth of the market. The market share, historical data, and estimated statistics of each segment have been included in the scope of the research study.

The global market for human embryonic stem cells has been divided into Asia Pacific, Europe, Asia Pacific, and Rest of the World. Among these regions, presently, North America leads the global market for human embryonic stem cells, followed by Europe. The rapid growth of this region can be attributed to the growing prevalence of malignant and cardiac diseases. On the other hand, emerging countries in the Middle East, Asia Pacific, and Latin America are projected to grow at a fast pace owing to the booming medical tourism and developing markets for contract research outsourcing in these regions.

Browse Report with TOC: http://www.transparencymarketresearch.com/human-embryonic-stem-cells.html

Furthermore, the research study analyzes the competitive scenario of the global market for human embryonic stem cells, including the company profiles, contact information, business strategies, SWOT analysis, mergers and acquisitions, financial overview, and recent developments of major players. Some of the major players operating in the global market for human embryonic stem cells are Vitrolife AB, BD Biosciences, R&D Systems, Inc., Millipore Corporation, Geron Corporation, Tataa Biocenter, Thermo Scientific, Australian Stem Cell Centre, Invitrogen Corporation, SABiosciences Corporation, Viacyte, Inc., and Cellartis AB.

A new market research study by Transparency Market Research offers a comprehensive analysis of the human embryonic stem cells market across the globe. The research report, titled “Human Embryonic Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” further presents the forecast statistics of the overall market with the help of tables, charts, and infographics.

Human embryonic stem cells have the capability of differentiating into a number of cell types that make up the human body. Stem cells are derived from blastocysts and can replicate indefinitely and can also produce non-regenerative tissues, including myocardial and neural cells. As a result, human embryonic stem cells are increasingly being used for treating several genetic and blood disorders such as cancer and various disorders related to the immune system.

The growing research and development activities in the human embryonic stem cells market are one of the major factors fuelling the growth of the market. In addition, developing stem cell banking services and growing medical tourism are further augmenting the growth of the global market for human embryonic stem cells throughout the forecast period. Moreover, the growing incidence of neurological and cardiac disorders worldwide, due to the hectic lifestyle of the global population, and increasing availability of funds from several organizations are also estimated to fuel the growth of the market.

The global market for human embryonic stem cells has been segmented on the basis of application into regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing. The technological advancement in this field is estimated to increase its application in diverse sectors, resulting in rapid growth of the market. The market share, historical data, and estimated statistics of each segment have been included in the scope of the research study.

The global market for human embryonic stem cells has been divided into Asia Pacific, Europe, Asia Pacific, and Rest of the World. Among these regions, presently, North America leads the global market for human embryonic stem cells, followed by Europe. The rapid growth of this region can be attributed to the growing prevalence of malignant and cardiac diseases. On the other hand, emerging countries in the Middle East, Asia Pacific, and Latin America are projected to grow at a fast pace owing to the booming medical tourism and developing markets for contract research outsourcing in these regions.

Furthermore, the research study analyzes the competitive scenario of the global market for human embryonic stem cells, including the company profiles, contact information, business strategies, SWOT analysis, mergers and acquisitions, financial overview, and recent developments of major players. Some of the major players operating in the global market for human embryonic stem cells are Vitrolife AB, BD Biosciences, R&D Systems, Inc., Millipore Corporation, Geron Corporation, Tataa Biocenter, Thermo Scientific, Australian Stem Cell Centre, Invitrogen Corporation, SABiosciences Corporation, Viacyte, Inc., and Cellartis AB.

Contact

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.